Kenji Ishitsuka

Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

Takashi Ishida, Tatsuro Joh, Naokuni Uike et al. · Journal of Clinical Oncology · 2012 · 649 citations · Full text

Medicine, Oncology, Pharmacology +17

Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells

Teru Hideshima, Laurence Catley, Hiroshi Yasui et al. · Blood · 2006 · 421 citations · Full text

Medicine, Oncology, Pharmacology +15

Treatment and survival among 1594 patients with ATL

Hiroo Katsuya, Kenji Ishitsuka, Atae Utsunomiya et al. · Blood · 2015 · 310 citations · Full text

Medicine, Oncology, Medical Oncology +1

Bortezomib Mediates Antiangiogenesis in Multiple Myeloma via Direct and Indirect Effects on Endothelial Cells

Aldo M. Roccaro, Teru Hideshima, Noopur Raje et al. · Cancer Research · 2006 · 285 citations

Medicine, Oncology, Pharmacology +17

Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase <scp>II</scp> study

Takashi Ishida, Tatsuro Jo, Shigeki Takemoto et al. · British Journal of Haematology · 2015 · 262 citations · Full text

Medicine, Oncology, Pharmacology +17